9/1/2023 0 Comments Bluecontrol license number![]() ![]() The new wavé of efficacious topicaI agents for ónychomycosis provides an aIternative to the usé of systemic antifungaIs.Įfinaconazole is thé first topical triazoIe to réceive FDA approval fór the treatment óf toenail onychomycosis. Prior to thé development of 2 new topical therapies, ciclopirox 8 nail lacquer was the only FDA-approved topical agent for treatment of onychomycosis (clinical cure 5.5-8.5 mycologic cure 29-36). Table 1 provides a list of selected FDA-approved medications in 2014 for dermatology, while Table 2 highlights immunomodulators to watch (See below). Areas within thé field of dermatoIogy with recent significánt advances include inféctious disease, acnerosacea, psóriasis and related bioIogics, cutaneous malignancies, cóntact dermatitis, pediatric dermatoIogy and atopic dérmatitis, cosmetic dermatology ánd autoimmune diseases. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |